Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

15,213 questions in 2,394 reviews

current versions
No studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Prebiotic vs another prebiotic
Graft infection · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs probiotic
eGFR · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs probiotic
Albuminuria or proteinuria · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs probiotic
Indoxyl sulfate · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs probiotic
Change in any GI upset or intolerance · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs probiotic
Microbiota composition · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs probiotic
Graft function · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs probiotic
Graft infection · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs another synbiotic
Microbiota composition · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs another probiotic
Albuminuria or proteinuria · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs another probiotic
Indoxyl sulfate · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs another probiotic
Change in any GI upset or intolerance · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs another probiotic
Microbiota composition · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs another probiotic
Graft function · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs another probiotic
Graft infection · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs placebo or no treatment
Albuminuria or proteinuria · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs placebo or no treatment
Indoxyl sulfate · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs another synbiotic
Graft function · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs placebo or no treatment
Microbiota composition · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs placebo or no treatment
Graft function · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs placebo or no treatment
Graft infection · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs placebo or no treatment
eGFR · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs placebo or no treatment
Albuminuria or proteinuria · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs another synbiotic
Graft infection · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs placebo or no treatment
Any change in GI upset or intolerance · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs placebo or no treatment
Graft function · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Prebiotic vs placebo or no treatment
Graft infection · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs placebo or no treatment
Microbiota composition · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs placebo or no treatment
Graft function · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Probiotic vs placebo or no treatment
Graft infection · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Synbiotic vs prebiotic
Albuminuria or proteinuria · people with CKD
Synbiotics, prebiotics and probiotics for people with chronic kidney disease (2023) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Tranexamic acid vs placebo
Red cell transfusions (units per participant) up to 30 days post surgery · people aged 18 and over undergoing vascular surgery
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review… (2023) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Fibrin sealant vs usual care
Red cell transfusions (units per participant) up to 30 days post surgery · people aged 18 and over undergoing vascular surgery
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review… (2023) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Fibrin sealant vs usual care
Risk of receiving any allogeneic blood product up to 30 days · people aged 18 and over undergoing vascular surgery
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review… (2023) · Cochrane
no estimate extractedNRNo studies
CPAP and supportive care vs supportive care
Failed CPAP · preterm infants with apnoea of prematurity
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
Variable flow vs bubble CPAP
Adverse events · preterm infants, 24 to 29 weeks gestation and mean age 18 days with apnoea of prematurity
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
Variable flow vs bubble CPAP
Long‐term neurodevelopmental outcomes · preterm infants, 24 to 29 weeks gestation and mean age 18 days with apnoea of prematurity
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
Infant Flow CPAP vs Medijet CPAP
Long‐term neurodevelopmental outcomes · preterm infants with apnoea of prematurity (gestation 27 weeks, age not stated)
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
CPAP and supportive care vs supportive care
Mean apnoea events · preterm infants with apnoea of prematurity
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
CPAP and supportive care vs supportive care
Adverse events · preterm infants with apnoea of prematurity
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
CPAP and supportive care vs supportive care
Long‐term neurodevelopmental outcomes · preterm infants with apnoea of prematurity
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
Variable flow vs ventilator CPAP
Long‐term neurodevelopmental outcomes · preterm infants with apnoea of prematurity (median age 9 days)
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
Variable flow vs bubble CPAP
Failed CPAP · preterm infants, 24 to 29 weeks gestation and mean age 18 days with apnoea of prematurity
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
Variable flow vs bubble CPAP
Mean apnoea events · preterm infants, 24 to 29 weeks gestation and mean age 18 days with apnoea of prematurity
Continuous positive airway pressure (CPAP) for apnoea of prematurity (2023) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pravastatin 10 to 80 mg/day (6 to 156 weeks) · participants with normal or abnormal lipid profiles
Pravastatin for lowering lipids (2023) · Cochrane
no estimate extractedNRNo studies
Gait training protocol focused on impairment level vs gait training protocol focused on task level
Quality of life · people with transtibial amputation due to peripheral arterial disease or diabetes
Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane
no estimate extractedNRNo studies
Gait training protocol focused on impairment level vs gait training protocol focused on task level
Phantom limb pain frequency · people with transtibial amputation due to peripheral arterial disease or diabetes
Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane
no estimate extractedNRNo studies
Motor imaging vs usual care
Adverse events · people with transtibial amputation due to peripheral arterial disease or diabetes
Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane
no estimate extractedNRNo studies
Motor imaging vs usual care
Mortality – all causes · people with transtibial amputation due to peripheral arterial disease or diabetes
Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane
no estimate extractedNRNo studies
Motor imaging vs usual care
Quality of life · people with transtibial amputation due to peripheral arterial disease or diabetes
Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial… (2023) · Cochrane
no estimate extractedNRNo studies